JARDIANCE

At a glance

Key dates

1. Approval

   FDA approval date of this drug product.

   Aug 01, 2014

   12 yr 1 mo ago

2. Today

3. Exclusivity ends · NPP

   New patient population exclusivity (3 years)

   Jun 20, 2026

   in 1 d

4. Exclusivity ends · I-922

   New indication exclusivity (3 years)

   Sep 21, 2026

   in 3 mo

5. Exclusivity ends · PED

   Pediatric exclusivity (adds 6 months)

   Dec 20, 2026

   in 6 mo

6. Patent 7713938 expires

   Listed drug substance patent expiration.

   Apr 15, 2027

   in 10 mo

7. Patent 7713938*PED expires

   Listed listed patent expiration.

   Oct 15, 2027

   in 1 yr 4 mo

8. Patent 7579449 expires

   Listed drug substance patent expiration.

   Aug 01, 2028

   in 2 yr 2 mo

9. Patent 7579449*PED expires

   Listed listed patent expiration.

   Feb 01, 2029

   in 2 yr 8 mo

10. Patent 8551957 expires

    Listed method-of-use patent (U-1651) expiration.

    Oct 14, 2029

    in 3 yr 4 mo

11. Patent 12115179 expires

    Listed method-of-use patent (U-4023) expiration.

    Feb 11, 2030

    in 3 yr 8 mo

12. Patent 8551957*PED expires

    Listed listed patent expiration.

    Apr 14, 2030

    in 3 yr 11 mo

13. Patent 12115179*PED expires

    Listed listed patent expiration.

    Aug 11, 2030

    in 4 yr 2 mo

14. Patent 12527810 expires

    Listed method-of-use patent (U-4403) expiration.

    Apr 22, 2033

    in 6 yr 11 mo

15. Patent 12527810*PED expires

    Listed listed patent expiration.

    Oct 22, 2033

    in 7 yr 5 mo

16. Patent 10258637 expires

    Listed method-of-use patent (U-2290) expiration.

    Apr 03, 2034

    in 7 yr 11 mo

17. Patent 11090323 expires

    Listed method-of-use patent (U-3191) expiration.

    Apr 03, 2034

    in 7 yr 11 mo

18. Patent 11666590 expires

    Listed method-of-use patent (U-3691) expiration.

    Apr 03, 2034

    in 7 yr 11 mo

19. Patent 11813275 expires

    Listed method-of-use patent (U-3759) expiration.

    Apr 03, 2034

    in 7 yr 11 mo

20. Patent 11813275 expires

    Listed method-of-use patent (U-3760) expiration.

    Apr 03, 2034

    in 7 yr 11 mo

21. Patent 11833166 expires

    Listed method-of-use patent (U-3776) expiration.

    Apr 03, 2034

    in 7 yr 11 mo

22. Patent 11833166 expires

    Listed method-of-use patent (U-3777) expiration.

    Apr 03, 2034

    in 7 yr 11 mo

23. Patent 12263153 expires

    Listed method-of-use patent (U-4171) expiration.

    Apr 03, 2034

    in 7 yr 11 mo

24. Patent 12427162 expires

    Listed method-of-use patent (U-4287) expiration.

    Apr 03, 2034

    in 7 yr 11 mo

25. Patent 12433906 expires

    Listed method-of-use patent (U-4304) expiration.

    Apr 03, 2034

    in 7 yr 11 mo

26. Patent 12433906 expires

    Listed method-of-use patent (U-4293) expiration.

    Apr 03, 2034

    in 7 yr 11 mo

27. Patent 12433906 expires

    Listed method-of-use patent (U-4294) expiration.

    Apr 03, 2034

    in 7 yr 11 mo

28. Patent 12433906 expires

    Listed method-of-use patent (U-4295) expiration.

    Apr 03, 2034

    in 7 yr 11 mo

29. Patent 12433906 expires

    Listed method-of-use patent (U-4296) expiration.

    Apr 03, 2034

    in 7 yr 11 mo

30. Patent 9949997 expires

    Listed method-of-use patent (U-2292) expiration.

    May 17, 2034

    in 8 yr

31. Patent 9949997 expires

    Listed method-of-use patent (U-3325) expiration.

    May 17, 2034

    in 8 yr

32. Patent 9949997 expires

    Listed method-of-use patent (U-3199) expiration.

    May 17, 2034

    in 8 yr

33. Patent 9949998 expires

    Listed method-of-use patent (U-2290) expiration.

    Jun 11, 2034

    in 8 yr 1 mo

34. Patent 10258637*PED expires

    Listed listed patent expiration.

    Oct 03, 2034

    in 8 yr 5 mo

35. Patent 11090323*PED expires

    Listed listed patent expiration.

    Oct 03, 2034

    in 8 yr 5 mo

36. Patent 11813275*PED expires

    Listed listed patent expiration.

    Oct 03, 2034

    in 8 yr 5 mo

37. Patent 11833166*PED expires

    Listed listed patent expiration.

    Oct 03, 2034

    in 8 yr 5 mo

38. Patent 12433906*PED expires

    Listed listed patent expiration.

    Oct 03, 2034

    in 8 yr 5 mo

39. Patent 9949997*PED expires

    Listed listed patent expiration.

    Nov 17, 2034

    in 8 yr 6 mo

40. Patent 9949998*PED expires

    Listed listed patent expiration.

    Dec 11, 2034

    in 8 yr 7 mo

Pharmaceutical detail

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

• EMPAGLIFLOZINGeneric (ANDA)

  ANDA 212138 · ZYDUS PHARMS

  2022

Marketing exclusivity (3)

• NPPNew patient population exclusivity (3 years)

  Jun 20, 2026

  in 1 d

• I-922New indication exclusivity (3 years)

  Sep 21, 2026

  in 3 mo

• PEDPediatric exclusivity (adds 6 months)

  Dec 20, 2026

  in 6 mo

Listed patents (35)